Savara (SVRA) Operating Expenses (2010 - 2026)

Savara (SVRA) reported Operating Expenses of $39.0 million for Q1 2026, up 37.12% year-over-year from $28.4 million in Q1 2025, and up 16.67% quarter-over-quarter from $33.4 million in Q4 2025.

Savara (SVRA) Operating Expenses (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Operating Expenses data on file, last reported at $39.0 million in Q1 2026.

  • Operating Expenses for Q1 2026 came in at $39.0 million, up 37.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $134.1 million (up 22.86% YoY), and the FY2025 annual result was $123.5 million, up 19.72% from the prior year.
  • Operating Expenses climbed to $39.0 million in Q1 2026 per SVRA's latest filing, from $33.4 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $39.0 million in Q1 2026 and troughed at $8.0 million in Q1 2022.
  • A 5-year average of $21.4 million and a median of $22.5 million in 2024 frame the typical range for Operating Expenses.
  • The sharpest annual moves came in 2022 and 2024: Operating Expenses fell 22.74% in 2022, then surged 89.76% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $10.9 million in 2022, then soared by 62.11% to $17.6 million in 2023, then soared by 76.82% to $31.2 million in 2024, then advanced by 7.2% to $33.4 million in 2025, then advanced by 16.67% to $39.0 million in 2026.
  • Business Quant data shows SVRA's Operating Expenses at $39.0 million in Q1 2026, $33.4 million in Q4 2025, and $30.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.33 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 32.68 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -138.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 15.76 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 574,669.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.85 Bn
9 Abivax 91.96 Bn 91.96 Bn - -67.40 Mn
10 Savara 1.39 Bn 1.39 Bn - 38.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 38.99 Mn
Dec 31, 2025 33.42 Mn
Sep 30, 2025 30.26 Mn
Jun 30, 2025 31.44 Mn
Mar 31, 2025 28.44 Mn
Dec 31, 2024 31.17 Mn
Sep 30, 2024 26.36 Mn
Jun 30, 2024 23.19 Mn
Mar 31, 2024 22.48 Mn
Dec 31, 2023 17.63 Mn
Sep 30, 2023 18.04 Mn
Jun 30, 2023 12.22 Mn
Mar 31, 2023 12.11 Mn
Dec 31, 2022 10.88 Mn
Sep 30, 2022 10.54 Mn
Jun 30, 2022 9.38 Mn
Mar 31, 2022 8.05 Mn
Dec 31, 2021 10.64 Mn
Sep 30, 2021 9.97 Mn
Jun 30, 2021 10.45 Mn